Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Simon C. Lovell is active.

Publication


Featured researches published by Simon C. Lovell.


Proteins | 2003

Structure validation by Cα geometry: φ,ψ and Cβ deviation

Simon C. Lovell; Ian W. Davis; W. Bryan Arendall; Paul I. W. de Bakker; J. Michael Word; Michael G. Prisant; Jane S. Richardson; David C. Richardson

Geometrical validation around the Cα is described, with a new Cβ measure and updated Ramachandran plot. Deviation of the observed Cβ atom from ideal position provides a single measure encapsulating the major structure‐validation information contained in bond angle distortions. Cβ deviation is sensitive to incompatibilities between sidechain and backbone caused by misfit conformations or inappropriate refinement restraints. A new ϕ,ψ plot using density‐dependent smoothing for 81,234 non‐Gly, non‐Pro, and non‐prePro residues with B < 30 from 500 high‐resolution proteins shows sharp boundaries at critical edges and clear delineation between large empty areas and regions that are allowed but disfavored. One such region is the γ‐turn conformation near +75°,−60°, counted as forbidden by common structure‐validation programs; however, it occurs in well‐ordered parts of good structures, it is overrepresented near functional sites, and strain is partly compensated by the γ‐turn H‐bond. Favored and allowed ϕ,ψ regions are also defined for Pro, pre‐Pro, and Gly (important because Gly ϕ,ψ angles are more permissive but less accurately determined). Details of these accurate empirical distributions are poorly predicted by previous theoretical calculations, including a region left of α‐helix, which rates as favorable in energy yet rarely occurs. A proposed factor explaining this discrepancy is that crowding of the two‐peptide NHs permits donating only a single H‐bond. New calculations by Hu et al. [Proteins 2002 (this issue)] for Ala and Gly dipeptides, using mixed quantum mechanics and molecular mechanics, fit our nonrepetitive data in excellent detail. To run our geometrical evaluations on a user‐uploaded file, see MOLPROBITY (http://kinemage.biochem.duke.edu) or RAMPAGE (http://www‐cryst.bioc.cam.ac.uk/rampage). Proteins 2003;50:437–450.


Nature Genetics | 2012

Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature

Gillian I. Rice; Paul R. Kasher; Gabriella M.A. Forte; Niamh M. Mannion; Sam M. Greenwood; Marcin Szynkiewicz; Jonathan E. Dickerson; Sanjeev Bhaskar; Massimiliano Zampini; Tracy A. Briggs; Emma M. Jenkinson; Carlos A. Bacino; Roberta Battini; Enrico Bertini; Paul A. Brogan; Louise Brueton; Marialuisa Carpanelli; Corinne De Laet; Pascale de Lonlay; Mireia del Toro; Isabelle Desguerre; Elisa Fazzi; Angels García-Cazorla; Arvid Heiberg; Masakazu Kawaguchi; Ram Kumar; Jean-Pierre Lin; Charles Marques Lourenço; Alison Male; Wilson Marques

Adenosine deaminases acting on RNA (ADARs) catalyze the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) and thereby potentially alter the information content and structure of cellular RNAs. Notably, although the overwhelming majority of such editing events occur in transcripts derived from Alu repeat elements, the biological function of non-coding RNA editing remains uncertain. Here, we show that mutations in ADAR1 (also known as ADAR) cause the autoimmune disorder Aicardi-Goutières syndrome (AGS). As in Adar1-null mice, the human disease state is associated with upregulation of interferon-stimulated genes, indicating a possible role for ADAR1 as a suppressor of type I interferon signaling. Considering recent insights derived from the study of other AGS-related proteins, we speculate that ADAR1 may limit the cytoplasmic accumulation of the dsRNA generated from genomic repetitive elements.


Cellular and Molecular Life Sciences | 2008

The leucine-rich repeat structure

Jordi Bella; K. L. Hindle; P. A. McEwan; Simon C. Lovell

Abstract.The leucine-rich repeat is a widespread structural motif of 20–30 amino acids with a characteristic repetitive sequence pattern rich in leucines. Leucine-rich repeat domains are built from tandems of two or more repeats and form curved solenoid structures that are particularly suitable for protein-protein interactions. Thousands of protein sequences containing leucine-rich repeats have been identified by automatic annotation methods. Three-dimensional structures of leucine-rich repeat domains determined to date reveal a degree of structural variability that translates into the considerable functional versatility of this protein superfamily. As the essential structural principles become well established, the leucine-rich repeat architecture is emerging as an attractive framework for structural prediction and protein engineering. This review presents an update of the current understanding of leucine-rich repeat structure at the primary, secondary, tertiary and quaternary levels and discusses specific examples from recently determined three-dimensional structures.


Nature Biotechnology | 2008

Protein-protein interaction networks and biology - What's the connection?

Luke Hakes; John W. Pinney; David Robertson; Simon C. Lovell

Analysis of protein-protein interaction networks is an increasingly popular means to infer biological insight, but is close enough attention being paid to data handling protocols and the degree of bias in the data?


The EMBO Journal | 2007

ERp57 is essential for efficient folding of glycoproteins sharing common structural domains

Catherine E. Jessop; Seema Chakravarthi; Natalio Garbi; Günter J. Hämmerling; Simon C. Lovell; Neil J. Bulleid

ERp57 is a member of the protein disulphide isomerase family of oxidoreductases, which are involved in native disulphide bond formation in the endoplasmic reticulum of mammalian cells. This enzyme has been shown to be associated with both calnexin and calreticulin and, therefore, has been proposed to be a glycoprotein‐specific oxidoreductase. Here, we identify endogenous substrates for ERp57 by trapping mixed disulphide intermediates between enzyme and substrate. Our results demonstrate that the substrates for this enzyme are mostly heavily glycosylated, disulphide bonded proteins. In addition, we show that the substrate proteins share common structural domains, indicating that substrate specificity may involve specific structural features as well as the presence of an oligosaccharide side chain. We also show that the folding of two of the endogenous substrates for ERp57 is impaired in ERp57 knockout cells and that prevention of an interaction with calnexin or calreticulin perturbs the folding of some, but not all, substrates with multiple disulphide bonds. These results suggest a specific role for ERp57 in the isomerisation of non‐native disulphide bonds in specific glycoprotein substrates.


Nature Genetics | 2011

Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature

Tracy A. Briggs; Gillian I. Rice; Sarah B. Daly; Jill Urquhart; Hannah Gornall; Brigitte Bader-Meunier; Kannan Baskar; Shankar Baskar; Veronique Baudouin; Michael W. Beresford; Graeme C.M. Black; Rebecca J. Dearman; Francis de Zegher; Emily S. Foster; Camille Frances; Alison R. Hayman; Emma Hilton; Chantal Job-Deslandre; M. L. Kulkarni; Martine Le Merrer; Agnès Linglart; Simon C. Lovell; Kathrin Maurer; L. Musset; Vincent Navarro; Capucine Picard; Anne Puel; Frédéric Rieux-Laucat; Chaim M. Roifman; Sabine Scholl-Bürgi

We studied ten individuals from eight families showing features consistent with the immuno-osseous dysplasia spondyloenchondrodysplasia. Of particular note was the diverse spectrum of autoimmune phenotypes observed in these individuals (cases), including systemic lupus erythematosus, Sjögrens syndrome, hemolytic anemia, thrombocytopenia, hypothyroidism, inflammatory myositis, Raynauds disease and vitiligo. Haplotype data indicated the disease gene to be on chromosome 19p13, and linkage analysis yielded a combined multipoint log10 odds (LOD) score of 3.6. Sequencing of ACP5, encoding tartrate-resistant acid phosphatase, identified biallelic mutations in each of the cases studied, and in vivo testing confirmed a loss of expressed protein. All eight cases assayed showed elevated serum interferon alpha activity, and gene expression profiling in whole blood defined a type I interferon signature. Our findings reveal a previously unrecognized link between tartrate-resistant acid phosphatase activity and interferon metabolism and highlight the importance of type I interferon in the genesis of autoimmunity.


Nature Genetics | 2012

Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus

Beverley Anderson; Paul R. Kasher; Josephine Mayer; Marcin Szynkiewicz; Emma M. Jenkinson; Sanjeev Bhaskar; Jill Urquhart; Sarah B. Daly; Jonathan E. Dickerson; James O'Sullivan; Elisabeth Oppliger Leibundgut; Joanne Muter; Ghada M H Abdel-Salem; Riyana Babul-Hirji; Peter Baxter; Andrea Berger; Luisa Bonafé; Janice E Brunstom-Hernandez; Johannes A Buckard; David Chitayat; Wk Chong; Duccio Maria Cordelli; Patrick Ferreira; Joel Victor Fluss; Ewan H. Forrest; Emilio Franzoni; Caterina Garone; Simon Hammans; Gunnar Houge; Imelda Hughes

Coats plus is a highly pleiotropic disorder particularly affecting the eye, brain, bone and gastrointestinal tract. Here, we show that Coats plus results from mutations in CTC1, encoding conserved telomere maintenance component 1, a member of the mammalian homolog of the yeast heterotrimeric CST telomeric capping complex. Consistent with the observation of shortened telomeres in an Arabidopsis CTC1 mutant and the phenotypic overlap of Coats plus with the telomeric maintenance disorders comprising dyskeratosis congenita, we observed shortened telomeres in three individuals with Coats plus and an increase in spontaneous γH2AX-positive cells in cell lines derived from two affected individuals. CTC1 is also a subunit of the α-accessory factor (AAF) complex, stimulating the activity of DNA polymerase-α primase, the only enzyme known to initiate DNA replication in eukaryotic cells. Thus, CTC1 may have a function in DNA metabolism that is necessary for but not specific to telomeric integrity.


Genome Biology | 2007

All duplicates are not equal: the difference between small-scale and genome duplication

Luke Hakes; John W. Pinney; Simon C. Lovell; Stephen G. Oliver; David Robertson

BackgroundGenes in populations are in constant flux, being gained through duplication and occasionally retained or, more frequently, lost from the genome. In this study we compare pairs of identifiable gene duplicates generated by small-scale (predominantly single-gene) duplications with those created by a large-scale gene duplication event (whole-genome duplication) in the yeast Saccharomyces cerevisiae.ResultsWe find a number of quantifiable differences between these data sets. Whole-genome duplicates tend to exhibit less profound phenotypic effects when deleted, are functionally less divergent, and are associated with a different set of functions than their small-scale duplicate counterparts. At first sight, either of these latter two features could provide a plausible mechanism by which the difference in dispensability might arise. However, we uncover no evidence suggesting that this is the case. We find that the difference in dispensability observed between the two duplicate types is limited to gene products found within protein complexes, and probably results from differences in the relative strength of the evolutionary pressures present following each type of duplication event.ConclusionGenes, and the proteins they specify, originating from small-scale and whole-genome duplication events differ in quantifiable ways. We infer that this is not due to their association with different functional categories; rather, it is a direct result of biases in gene retention.


Protein Science | 2012

The interface of protein structure, protein biophysics, and molecular evolution

David A. Liberles; Sarah A. Teichmann; Ivet Bahar; Ugo Bastolla; Jesse D. Bloom; Erich Bornberg-Bauer; Lucy J. Colwell; A. P. Jason de Koning; Nikolay V. Dokholyan; Julian J. Echave; Arne Elofsson; Dietlind L. Gerloff; Richard A. Goldstein; Johan A. Grahnen; Mark T. Holder; Clemens Lakner; Nicholas Lartillot; Simon C. Lovell; Gavin J. P. Naylor; Tina Perica; David D. Pollock; Tal Pupko; Lynne Regan; Andrew J. Roger; Nimrod D. Rubinstein; Eugene I. Shakhnovich; Kimmen Sjölander; Shamil R. Sunyaev; Ashley I. Teufel; Jeffrey L. Thorne

Abstract The interface of protein structural biology, protein biophysics, molecular evolution, and molecular population genetics forms the foundations for a mechanistic understanding of many aspects of protein biochemistry. Current efforts in interdisciplinary protein modeling are in their infancy and the state‐of‐the art of such models is described. Beyond the relationship between amino acid substitution and static protein structure, protein function, and corresponding organismal fitness, other considerations are also discussed. More complex mutational processes such as insertion and deletion and domain rearrangements and even circular permutations should be evaluated. The role of intrinsically disordered proteins is still controversial, but may be increasingly important to consider. Protein geometry and protein dynamics as a deviation from static considerations of protein structure are also important. Protein expression level is known to be a major determinant of evolutionary rate and several considerations including selection at the mRNA level and the role of interaction specificity are discussed. Lastly, the relationship between modeling and needed high‐throughput experimental data as well as experimental examination of protein evolution using ancestral sequence resurrection and in vitro biochemistry are presented, towards an aim of ultimately generating better models for biological inference and prediction.


Molecular Biology and Evolution | 2010

An Integrated View of Molecular Coevolution in Protein–Protein Interactions

Simon C. Lovell; David Robertson

Protein-protein interactions effectively mediate molecular function. They are the result of specific interactions between protein interfaces and are maintained by the action of evolutionary pressure on the regions of the interacting proteins that contribute to binding. For the most part, selection restricts amino acid replacements, accounting for the conservation of binding interfaces. However, in some cases, change in one protein will be mitigated by compensatory change in its binding partner, maintaining function in the face of evolutionary change. There have been several attempts to use correlations in sequence evolution to predict interactions of proteins. Most commonly, these approaches use the entire sequence to identify correlations and so infer probable binding. However, other factors such as shared evolutionary history and similarities in the rates of evolution confound these whole-sequence-based approaches. Here, we discuss recent work on this topic and argue that both site-specific coevolutionary change and whole-sequence evolution contribute to evolutionary signals in sets of interacting proteins. We discuss the relative effects of both types of selection and how they might be identified. This permits an integrated view of protein-protein interactions, their evolution, and coevolution.

Collaboration


Dive into the Simon C. Lovell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Talavera

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Julia Handl

University of Manchester

View shared research outputs
Top Co-Authors

Avatar

Ryan M. Ames

University of Manchester

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Luke Hakes

University of Manchester

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge